SCHEMBL2388282

SCHEMBL2388282

CC1=Cc2c(-c3ccc(C(C)(C)C)cc3)cccc2C1[Si](C)(C)Cl

nearest known ligand 0.35

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
S1PR1 P21453 1/20 0.34
PTAFR P25105 1/20 0.33
BRD4 O60885 1/20 0.32
CREBBP Q92793 1/20 0.32
KIF11 P52732 2/20 0.32
DGAT1 O75907 2/20 0.31
NR1H4 Q96RI1 3/20 0.31
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1455223 0.89 NPC1 (0.36) NPC1RAB9ALMNATP53SMN1; SMN2
SCHEMBL5477563 0.88 RXRB (0.31) PTAFRKIF11
SCHEMBL15827904 0.86 ADORA3 (0.32) NPC1RAB9APTAFR
SCHEMBL3402757 0.86 NR1H4 (0.31) NPC1RAB9ALMNATP53SMN1; SMN2
SCHEMBL1825035 0.85 PDCD1 (0.33) NPC1RAB9ASMN1; SMN2BRD4
SCHEMBL22411215 0.84 NPC1 (0.33) NPC1RAB9ALMNATP53SMN1; SMN2
SCHEMBL1799580 0.84 NPC1 (0.33) NPC1RAB9ALMNATP53SMN1; SMN2
SCHEMBL30541994 0.84 NPC1 (0.33) NPC1RAB9ALMNATP53SMN1; SMN2
SCHEMBL3400017 0.84 PTAFR (0.33) NPC1RAB9ALMNATP53SMN1; SMN2
SCHEMBL5548512 0.83 BRD4 (0.32) NPC1RAB9ALMNATP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3131935-B1 NEW CATALYST SYSTEM FOR PRODUCING POLYETHYLENE COPOLYMERS IN A HIGH TEMPERATURE SOLUTION POLYMERIZATION PROCESS BOREALIS AG (AT) 2020-06-03 EP disclosed
US-10301411-B2 Catalyst system for producing polyethylene copolymers in a high temperature solution polymerization process BOREALIS AG (AT) 2019-05-28 US disclosed
EP-2746301-B1 Catalyst BOREALIS AG (AT) 2018-05-30 EP disclosed
US-9598517-B2 Catalysts BOREALIS AG (AT) 2017-03-21 US disclosed
US-9598517-B2 Catalysts BOREALIS AG (AT) 2017-03-21 US disclosed
US-20170037164-A1 NEW CATALYST SYSTEM FOR PRODUCING POLYETHYLENE COPOLYMERS IN A HIGH TEMPERATURE SOLUTION POLYMERIZATION PROCESS BOREALIS AG (AT) 2017-02-09 US disclosed
US-20170037164-A1 NEW CATALYST SYSTEM FOR PRODUCING POLYETHYLENE COPOLYMERS IN A HIGH TEMPERATURE SOLUTION POLYMERIZATION PROCESS BOREALIS AG (AT) 2017-02-09 US disclosed
US-20150344596-A1 CATALYSTS BOREALIS AG (AT) 2015-12-03 US disclosed
US-20150344596-A1 CATALYSTS BOREALIS AG (AT) 2015-12-03 US disclosed
US-20150344596-A1 CATALYSTS BOREALIS AG (AT) 2015-12-03 US disclosed
EP-1548037-A2 Random propylene-ethylene copolymers Basell Polyolefine GmbH (DE) 2005-06-29 EP disclosed
US-6872843-B2 Non-metallocene compounds, method for the production thereof and use of the same for the polymerization of olefins BASELL POLYOLEFINE GMBH (DE) 2005-03-29 US disclosed
EP-1511755-A1 TRANSITION METAL COMPOUNDS THEIR PREPARATION AND THEIR USE IN CATALYST SYSTEMS FOR THE POLYMERIZATION AND COPOLYMERIZATION OF OLEFINS Basell Polyolefine GmbH (DE) 2005-03-09 EP disclosed
US-20040171855-A1 Metallocenes, use in catalyst system for producing olefin polymers EQUISTAR CHEMICALS, LP 2004-09-02 US disclosed
EP-1397371-A1 METALLOCENES AND THEIR USE IN CATALYST SYSTEMS FOR PRODUCING OLEFIN POLYMERS Basell Polyolefine GmbH (DE) 2004-03-17 EP disclosed
US-20040023940-A1 Non-metallocene compounds, method for the production thereof and use of the same for the polymerisation of olefins EQUISTAR CHEMICALS, LP 2004-02-05 US disclosed
WO-2003106470-A1 TRANSITION METAL COMPOUNDS THEIR PREPARATION AND THEIR USE IN CATALYST SYSTEMS FOR THE POLYMERIZATION AND COPOLYMERIZATION OF OLEFINS BASELL POLYOLEFINE GMBH (DE) 2003-12-24 WO disclosed
US-6627764-B1 Titanium, hafnium or zirconium indenyl halide complexes; coordination catalysts BASELL POLYOLEFINE GMBH (DE) 2003-09-30 US disclosed
US-20030149199-A1 Transition metal compound, ligand system, catalyst system and the use of the latter for polymerisation and copolymerisation of olefins BASELL POLYPROPYLEN GMBH (DE) 2003-08-07 US disclosed
WO-2003000706-A1 METALLOCENES, USE IN CATALYST SYSTEMS FOR PRODUCING OLEFIN POLYMERS BASELL POLYOLEFINE GMBH (DE) 2003-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10301411-B2 Catalyst system for producing polyethylene copolymers in a high temperature solution polymerization process RPS8, MLX, HRH2 NPC1 2756/4885RAB9A 1006/4885LMNA 804/4885
US-20040171855-A1 Metallocenes, use in catalyst system for producing olefin polymers H1-4, H1-0, H1-10 NPC1 3067/4885RAB9A 2176/4885LMNA 4308/4885
US-20170037164-A1 NEW CATALYST SYSTEM FOR PRODUCING POLYETHYLENE COPOLYMERS IN A HIGH TEMPERATURE SOLUTION POLYMERIZATION PROCESS RPS8, HRH2, MLX NPC1 2613/4885RAB9A 753/4885LMNA 646/4885
US-20030149199-A1 Transition metal compound, ligand system, catalyst system and the use of the latter for polymerisation and copolymerisation of olefins PORCN, PGR, PPOX NPC1 4292/4885RAB9A 4819/4885LMNA 4444/4885
US-20040023940-A1 Non-metallocene compounds, method for the production thereof and use of the same for the polymerisation of olefins SOAT2, NOTUM, SOAT1 NPC1 923/4885RAB9A 4353/4885LMNA 4296/4885
US-20150344596-A1 CATALYSTS SFN, AP3S1, H1-2 NPC1 2306/4885RAB9A 1905/4885LMNA 1970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.